Entera Bio Ltd.
Price Action
Technical Summary
WEAKENINGEntera Bio Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 68), indicating performance broadly in line with the market. Earnings contraction of 24% provides fundamental context to the price action. However, price is extended 31% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.31 | +25.86% | ABOVE |
| 50 SMA | $1.26 | +31.12% | ABOVE |
| 100 SMA | $1.27 | +29.68% | ABOVE |
| 150 SMA | $1.47 | +12.31% | ABOVE |
| 200 SMA | $1.69 | -2.10% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ENTX in an uptrend right now?
ENTX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ENTX overbought or oversold?
ENTX's RSI (14) is 69. The stock is in neutral territory, neither overbought nor oversold.
Is ENTX outperforming the market?
ENTX has a Relative Strength (RS) Rating of 68 out of 99. ENTX is performing about average compared to the market.
Where is ENTX in its 52-week range?
ENTX is trading at $1.65, which is 51% of its 52-week high ($3.22) and 31% above its 52-week low ($0.93).
How volatile is ENTX?
ENTX has a Beta of 0.91 and 52-week volatility of 87%. It's less volatile than the S&P 500 - generally more stable.